Help
RSS
API
Feed
Maltego
Contact
Domain > ir.genenta.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2022-05-04
23.64.114.23
(
ClassC
)
2023-12-28
23.215.9.31
(
ClassC
)
2024-02-26
23.215.9.165
(
ClassC
)
2025-08-04
23.216.147.197
(
ClassC
)
Port 443
HTTP/1.1 200 OKContent-Language: enContent-Security-Policy: default-src self bam-cell.nr-data.net bam.nr-data.net cm.everesttech.net thomsonreuterscorporategroupweb.sc.omtrdc.net *.demdex.net www.google-analytics.com www.googletagmanager.com www.adobetag.com *.facebook.net api.nasdaqomx.wallst.com www.google.com *.addthis.com *.addthisedge.com www.googleadservices.com thomsonreuterscorporategroupweb.d2.sc.omtrdc.net stats.g.doubleclick.net *.sharethis.com *.pixel.parsely.com www.recaptcha.net *.gstatic.com c212.net pixel.mathtag.com *.kscope.io *.globenewswire.com *.accesswire.com *.businesswire.com *.prnewswire.com *.c212.net *.youtube.com *.vimeo.com *.media-server.com *.akamaihd.net media.corporate-ir.net *.unisonir.com cloudinary.com *.segment.com *.notified.com *.pendo.io data: www.genenta.com; connect-src self *.uni.wdc.west.com *.sharethis.com *.unisonir.com *.demdex.net bam-cell.nr-data.net bam.nr-data.net api.segment.io thomsonreuterscorporategroupweb.sc.omtrdc.net *.akamaihd.net *.notified.com *.pendo.io *.kscope.io *.imirwin.com; font-src self fonts.googleapis.com cloud.typography.com fonts.gstatic.com uninav.notified.com stackpath.bootstrapcdn.com *.kscope.io *.fontawesome.com data:; frame-src self s7.addthis.com tools.eurolandir.com www.google.com *.sharethis.com api.nasdaqomx.wallst.com *.demdex.net www.recaptcha.net cloudinary.com player.cloudinary.com *.notified.com *.globenewswire.com player.vimeo.com www.genenta.com; object-src self; script-src self unsafe-inline unsafe-eval *.recaptcha.net js-agent.newrelic.com *.jquery.com *.gstatic.com bam-cell.nr-data.net bam.nr-data.net *.akamaihd.net uninav.notified.com maxcdn.bootstrapcdn.com stackpath.bootstrapcdn.com https://assets.adobedtm.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com https://media-library.cloudinary.com https://uninav.notified.com https://unpkg.com https://upload-widget.cloudinary.com https://www.google.com https://www.recaptcha.net www.google.com; script-src-elem self unsafe-inline *.uni.wdc.west.com s7.addthis.com www.google.com www.googletagmanager.com www.google-analytics.com siteimproveanalytics.com cdn.parsely.com www.adobetag.com www.recaptcha.net *.gstatic.com *.sharethis.com *.akamaihd.net *.kscope.io *.unisonir.com js-agent.newrelic.com bam-cell.nr-data.net bam.nr-data.net code.jquery.com cdn.segment.com *.pendo.io *.notified.com *.imirwin.com go.genenta.com https://assets.adobedtm.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com https://media-library.cloudinary.com https://uninav.notified.com https://unpkg.com https://upload-widget.cloudinary.com https://www.google.com https://www.recaptcha.net; style-src self unsafe-inline uninav.notified.com fonts.googleapis.com maxcdn.bootstrapcdn.com stackpath.bootstrapcdn.com *.gstatic.com https://fonts.googleapis.com https://player.vimeo.com https://uninav.notified.com https://unpkg.com https://use.fontawesome.com; style-src-elem self unsafe-inline fonts.googleapis.com *.uni.wdc.west.com *.sharethis.com www.google.com ajax.googleapis.com *.kscope.io *.unisonir.com *.gstatic.com stackpath.bootstrapcdn.com maxcdn.bootstrapcdn.com *.notified.com *.pendo.io https://fonts.googleapis.com https://player.vimeo.com https://uninav.notified.com https://unpkg.com https://use.fontawesome.com; form-action selfContent-Type: text/html; charsetUTF-8ETag: 1754296139Expect-CT: max-age0, report-uri/report-expect-ct-violationFeature-Policy: accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr noneFrom-Origin: sameLast-Modified: Mon, 04 Aug 2025 08:28:59 GMTReferrer-Policy: no-referrer-when-downgradeStrict-Transport-Security: max-age31536000X-Age: 0X-Content-Type-Options: nosniffX-Drupal-Dynamic-Cache: UNCACHEABLE (poor cacheability)X-Frame-Options: SAMEORIGINX-Request-ID: v-11d7243c-710d-11f0-8d65-0385a89b27b5X-XSS-Protection: 1; modeblockX-EdgeConnect-MidMile-RTT: 29X-EdgeConnect-Origin-MEX-Latency: 847Cache-Control: public, max-age0, s-maxage2700Expires: Mon, 04 Aug 2025 08:29:00 GMTDate: Mon, 04 Aug 2025 08:29:00 GMTTransfer-Encoding: chunkedConnection: keep-aliveConnection: Transfer-Encoding !DOCTYPE html>html langen dirltr prefixog: https://ogp.me/ns#> head> meta charsetutf-8 />meta namedescription contentThe Investor Relations website contains information about Genenta Science's business for stockholders, potential investors, and financial analysts. />link relcanonical hrefhttps://ir.genenta.com/investor-relations/ />link relshortlink hrefhttps://ir.genenta.com/ />meta namereferrer contentno-referrer />meta propertyog:site_name contentGenenta Science />meta propertyog:type contentwebsite />meta propertyog:url contenthttps://ir.genenta.com/investor-relations />meta propertyog:title contentInvestor Relations | Genenta Science />meta propertyog:description contentThe Investor Relations website contains information about Genenta Science's business for stockholders, potential investors, and financial analysts. />meta nameGenerator contentDrupal 10 (https://www.drupal.org) />meta nameMobileOptimized contentwidth />meta nameHandheldFriendly contenttrue />meta nameviewport contentwidthdevice-width, initial-scale1.0 />link relicon href/sites/g/files/knoqqb97531/files/favicon.png typeimage/png />link relalternate hreflangen hrefhttps://ir.genenta.com/ /> title>Investor Relations | Genenta Science/title> link relstylesheet mediaall href/sites/g/files/knoqqb97531/files/css/css_hXxyiqGBQVIfJNwU7TLuzSv7pqSRD7foxrLd9UbIMDQ.css?delta0&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall href/sites/g/files/knoqqb97531/files/css/css_RnL9W2Jur1Q4YEeZvL8zbHW4HB5VVU1cQizEEDLiE3I.css?delta1&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall hrefhttps://use.fontawesome.com/releases/v6.4.2/css/all.css />link relstylesheet mediaall hrefhttps://fonts.googleapis.com/icon?familyMaterial+Icons />link relstylesheet mediaall hrefhttps://fonts.googleapis.com/css2?familyMaterial+Symbols+Outlined:opsz,wght,FILL,GRAD@20..48,100..700,0..1,-50..200 />link relstylesheet mediaall hrefhttps://unpkg.com/aos@2.3.1/dist/aos.css />link relstylesheet mediaall hrefhttps://unpkg.com/swiper@8/swiper-bundle.min.css />link relstylesheet mediaall href/sites/g/files/knoqqb97531/files/css/css_9BHABRiBsPlWUp3BiArTbwip_XXPJGe53mqFyB8WM4k.css?delta7&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaprint href/sites/g/files/knoqqb97531/files/css/css_xGEdS62e4YwJiavFLGny0mkFm8EzacAOuwtB1-_IzAU.css?delta8&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall href/sites/g/files/knoqqb97531/files/css/css_R-aRfjCkbe-jNvqccziTRno6p7CTDoKfdPP9t8W1lik.css?delta9&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall hrefhttps://player.vimeo.com/api/player.js />link relstylesheet mediaall href/sites/g/files/knoqqb97531/files/css/css_djMaFaKALa4NsG__y90IC7rkoeYB7Y10BYddeQuqris.css?delta11&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA /> script src/core/assets/vendor/modernizr/modernizr.min.js?v3.11.7>/script>script src/sites/g/files/knoqqb97531/files/js/js_QUCeWaZRpKO1UXqd34K-zpU4y97KzqWk-YeXSdKwcIQ.js?scopeheader&delta1&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script> /head> body classnir-node nir-node--type-nir-landing-page nir-node--5806 reborn_lite path-frontpage page-node-type-nir-landing-page> div idskip> a classvisually-hidden focusable skip-link href#main-menu> Skip to main navigation /a> /div> div classdialog-off-canvas-main-canvas data-off-canvas-main-canvas> header classd-flex flex-column bg-black min-vh-100> nav classndm-main-nav navbar navbar-light navbar-expand-xl py-0 ndm-navBg aria-labelMain Navigation> div classcontainer-xl llf-px-md-5 llf-px-4> a classnavbar-brand py-0 me-xl-4 d-flex align-items-center hrefhttps://www.genenta.com/> div classndm-logo-container me-2> div classndm-logo-wrap> img src/sites/g/files/knoqqb97531/themes/site/client_site/dist/images/genenta-logo.png altLink to Genenta Science Corporate Site> /div> /div> /a> button classnavbar-toggler typebutton data-bs-togglecollapse data-bs-target#navbarNav aria-controlsnavbarNav aria-expandedfalse aria-labelToggle navigation> span classnavbar-toggler-icon aria-hiddentrue>span>/span>/span> /button> div classcollapse navbar-collapse ps-xl-5 idnavbarNav> ul classnavbar-nav flex-grow-1 justify-content-xl-end> li classnav-item active-trail> a classnav-link is-active ndm-is-active item-is-active href/investor-relations data-drupal-link-system-pathnode/5806 titleMain Investor Relations Page> Overview /a> /li> li classdropdown nav-item > a classdropdown-toggle nav-link href/news-events/news-releases data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/5816 > News & Events /a> ul classdropdown-menu> li> a classdropdown-item href/news-events/news-releases data-drupal-link-system-pathnode/5816 > News Releases /a> /li> li> a classdropdown-item href/news-events/events data-drupal-link-system-pathnode/5821 > Events /a> /li> li> a classdropdown-item href/news-events/presentations data-drupal-link-system-pathnode/6571 > Presentations /a> /li> li> a classdropdown-item href/news-events/annual-shareholders-meeting data-drupal-link-system-pathnode/7891 > Annual Shareholders Meeting /a> /li> /ul> /li> li classdropdown nav-item > a classdropdown-toggle nav-link href/stock/stock-quote-chart data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/5911 > Stock /a> ul classdropdown-menu> li> a classdropdown-item href/stock/stock-quote-chart data-drupal-link-system-pathnode/5911 > Stock Quote & Chart /a> /li> li> a classdropdown-item href/stock/historical-price-lookup data-drupal-link-system-pathnode/5921 > Historical Price Lookup /a> /li> li> a classdropdown-item href/stock/investment-calculator data-drupal-link-system-pathnode/5926 > Investment Calculator /a> /li> li> a classdropdown-item href/stock/analyst-coverage data-drupal-link-system-pathnode/5896 > Analyst Coverage /a> /li> /ul> /li> li classdropdown nav-item > a classdropdown-toggle nav-link href/governance/documents-charters data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/5836 > Governance /a> ul classdropdown-menu> li> a classdropdown-item href/governance/documents-charters data-drupal-link-system-pathnode/5836 > Documents & Charters /a> /li> li> a classdropdown-item href/governance/loyalty-share-program data-drupal-link-system-pathnode/7886 > Loyalty Share Program - Voto Maggiorato /a> /li> li> a classdropdown-item hrefhttps://www.genenta.com/leadership/ target_blank > Leadership Team /a> /li> li> a classdropdown-item hrefhttps://www.genenta.com/board-of-directors/ target_blank > Board of Directors /a> /li> li> a classdropdown-item href/governance/committee-composition data-drupal-link-system-pathnode/5851 > Committee Composition /a> /li> /ul> /li> li classdropdown nav-item > a classdropdown-toggle nav-link href/financials/sec-filings data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/6016 > Financials /a> ul classdropdown-menu> li> a classdropdown-item href/financials/sec-filings data-drupal-link-system-pathnode/6016 > SEC Filings /a> /li> li> a classdropdown-item href/financials/financial-results data-drupal-link-system-pathnode/5871 > Financial Results /a> /li> /ul> /li> li classdropdown nav-item > a classdropdown-toggle nav-link href/ir-resources/investor-faqs data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/5941 > IR Resources /a> ul classdropdown-menu> li> a classdropdown-item href/ir-resources/investor-faqs data-drupal-link-system-pathnode/5941 > Investor FAQs /a> /li> li> a classdropdown-item href/ir-resources/email-alerts data-drupal-link-system-pathnode/5946 > Email Alerts /a> /li> li> a classdropdown-item href/ir-resources/contact-us data-drupal-link-system-pathnode/5981 > Contact Us /a> /li> /ul> /li> li classnav-item > a classnav-link href/stock/stock-quote-chart data-drupal-link-system-pathnode/5911 > stock feed /a> /li> /ul> /div> /div>/nav> div idnav_stock classd-none aria-hiddentrue> div classregion region-nav-stock> div idblock-client-site-stockquote data-storage-idnode:5871:flexible_layout classblock--market-data-block__stock-quote block--market-data-block__stock-quote--5871 block--nav-stock--market-data-block__stock-quote block--nav-stock--market-data-block__stock-quote--5871 block--af49aab0-ef14-46ee-aa9b-35ca0236b0b0 block--af49aab0-ef14-46ee-aa9b-35ca0236b0b0--5871 block block-nir-market-data-block block-market-data-block__stock-quote> div classstock-quote stock-quote__short> div classquote-wrapper> span class>/span> span class price-change>/span> /div>/div> /div> /div> /div> div classjumbotron ndm-full-image-sect ndm-overlay-opac-0 flex-grow-1 ndm-overlay d-flex flex-column bg-dark bg-primary> div classz0 ndm-hero-media ndm-hero-movement> img classobject-fit plax hero src/sites/g/files/knoqqb97531/themes/site/client_site/dist/images/t-cell-full-1.jpg alt /> /div> div classcontainer llf-px-lg-5 llf-px-4 position-relative d-flex flex-column flex-grow-1 justify-content-center ndm-pt-6 ndm-pb-8> div classregion region-hero> div idblock-client-site-gbbannerinfo classblock-content--nir-global-block block-content--nir-global-block--6466 block--block-contentd517eda5-9bf1-417e-bac0-e6ee0064a3cc block--block-contentd517eda5-9bf1-417e-bac0-e6ee0064a3cc--5806 block--hero--block-content--d517eda5-9bf1-417e-bac0-e6ee0064a3cc block--hero--block-content--d517eda5-9bf1-417e-bac0-e6ee0064a3cc--5806 block--4317c1c7-92ce-4fba-bd8f-40170d8fee6e block--4317c1c7-92ce-4fba-bd8f-40170d8fee6e--5806 block block-block-content block-block-contentd517eda5-9bf1-417e-bac0-e6ee0064a3cc> div classfield field--name-field-nir-global-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>h1 classmb-0>Investor Relations/h1>!--div classrow gx-5> div classcol-lg-8 col-xl-7> div classmt-5 d-flex flex-column flex-md-row> a classbtn btn-lg btn-primary mb-4 mb-md-0 me-md-4 href#>span>Latest Earnings/span>/a> a classbtn btn-lg btn-primary href#>span>Latest Annual Report/span>/a> /div> /div>/div>-->/div> /div> /div> /div> /div> /div> /header> main classclearfix idmain aria-labelMain content> div idcontent> div idcontent-area> div classlf-5806 idlfg-content> div classregion region-content> div data-drupal-messages-fallback classhidden>/div>div idblock-client-site-content classblock--system-main-block block--system-main-block--5806 block--content--system-main-block block--content--system-main-block--5806 block--6c9b6080-a195-4a22-8bcb-b527efbc0391 block--6c9b6080-a195-4a22-8bcb-b527efbc0391--5806 block block-system block-system-main-block> article classnode node--type-nir_landing_page node--view-mode-full clearfix> div> div classpanel-display pond clearfix > section classpy-5> div classcontainer llf-py-5 llf-px-lg-5 llf-px-3 text-center radix-layouts-header panel-panel> div classpanel-panel-inner> div classblock-region-header>div classblock-content--nir-lp-block block-content--nir-lp-block--7981 block--block-content4fb11198-68ba-480a-8e41-15cc26c21dfa block--block-content4fb11198-68ba-480a-8e41-15cc26c21dfa--5806 block--header--block-content--4fb11198-68ba-480a-8e41-15cc26c21dfa block--header--block-content--4fb11198-68ba-480a-8e41-15cc26c21dfa--5806 block--9f7e3e30-b88b-46fb-963c-4a869592493a block--9f7e3e30-b88b-46fb-963c-4a869592493a--5806 block block-block-content block-block-content4fb11198-68ba-480a-8e41-15cc26c21dfa> div classfield field--name-field-nir-lp-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-lp-block-body field--type-text-long field--label-hidden field__item>div>div classrow gx-5 gy-4 gy-md-0 align-items-center>div classcol-md-6>div classllf-mr-0 llf-mr-md-3>video width100% height300 controls posterhttps://www.genenta.com/wp-content/uploads/2025/01/video_terapy.jpg> source srchttps://www.genenta.com/wp-content/uploads/2025/01/genenta-therapy.mp4 typevideo/mp4> Your browser does not support the video tag. /video>/div>/div>div classcol-md-6 text-start>h2>About Genenta/h2>p>Genenta (Nasdaq: GNTA) is a clinical stage immuno-oncology company developing a proprietary hematopoietic stem cells therapy for the treatment of a variety of solid tumor cancers. Genentas first in class product candidate is Temferon™, which is designed to allow the expression of immune-therapeutic payloads within the tumor microenvironment by bone marrow derived myeloid cells and enable a durable and targeted response. Genenta has completed a Phase 1 trial for newly diagnosed Glioblastoma Multiforme patients with an unmethylated MGMT gene promoter, which suggests the potential reprogramming of the tumor microenvironment and inhibiting of myeloid induced tolerance, while allowing the induction of T cell responses, potentially breaking immune tolerance. Genenta has initiated in Q4 2024 a Phase 1/2a metastatic Renal Cell Carcinoma study that will also include combination with immune checkpoint inhibitors. Our treatments are designed as one-time monotherapies, but with the additional potential, when used in combination, to significantly enhance the efficacy of other approved therapeutics./p>!-- div classmt-4> a classbtn btn-primary ndm-learn-more href# aria-labelRead more about Genenta Science>Read More/a> /div> -->/div>/div>/div>/div> /div> /div>/div> /div> /div> /section> section classpy-5 home-esg-section> div classcontainer llf-py-5 llf-px-lg-5 llf-px-3> div classrow gx-5 justify-content-between> div classcol-md-6 mb-5 mb-md-0> div classradix-layouts-secondarycolumn1 panel-panel> div classpanel-panel-inner> div classblock-region-secondarycolumn1>div classblock-content--nir-lp-block block-content--nir-lp-block--8101 block--block-content7b206ac7-87e1-4882-a7a0-91fd371b0b85 block--block-content7b206ac7-87e1-4882-a7a0-91fd371b0b85--5806 block--secondarycolumn1--block-content--7b206ac7-87e1-4882-a7a0-91fd371b0b85 block--secondarycolumn1--block-content--7b206ac7-87e1-4882-a7a0-91fd371b0b85--5806 block--28ec7cc2-171f-4601-8ea9-4be0299c3044 block--28ec7cc2-171f-4601-8ea9-4be0299c3044--5806 block block-block-content block-block-content7b206ac7-87e1-4882-a7a0-91fd371b0b85> h2>Why Invest/h2> div classfield field--name-field-nir-lp-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-lp-block-body field--type-text-long field--label-hidden field__item>p>Genenta (Nasdaq: GNTA) is developing a first in class cell therapy/p>ul>li>Proprietary platform to provide durable and safe treatment for solid tumors/li>li>Generating clinical proof of concept for breaking immune tolerance/li>li>Partnership to take Genenta to the next stage/li>/ul>/div> /div> /div>/div> /div> /div> /div> div classcol-md-6> div classradix-layouts-secondarycolumn2 panel-panel> div classpanel-panel-inner> div classblock-region-secondarycolumn2>div classblock--img-viewer block--nir-assets__widget block--nir-assets__widget--5806 block--secondarycolumn2--nir-assets__widget block--secondarycolumn2--nir-assets__widget--5806 block--a64fc9e4-bf66-4426-b2c8-cda9b712ac2a block--a64fc9e4-bf66-4426-b2c8-cda9b712ac2a--5806 block block-nir-assets block-nir-assets__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classnir-widget--content> div classnir-widget--list > div classllf-text-center nir-widget--field nir-widget--asset--thumbnail float-left> div classfield-nir-thumbnail> div classfield__item>a href/static-files/f61df689-d895-4862-824f-b1f4f9d0971d target_blank>img src/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/assets/2025/07/23/13-13-03/August%20Thumbnail.png?itokldEjLipU altCorporate Presentation August 2025 thumbnail classimage-style-nir-asset-small />/a>/div> /div> /div> div classllf-mt-3 llf-text-center> a href/static-files/f61df689-d895-4862-824f-b1f4f9d0971d classbtn btn-primary ndm-learn-more aria-labelDownload Corporate Presentation target_blank>Download/a> /div> /div> /div> /div> /div> /div> /div>/div> /div> /div> /div> /div> /div> /section> section classpy-5 home-news-section> div classcontainer llf-py-5 llf-px-lg-5 llf-px-3 radix-layouts-column1 panel-panel> div classpanel-panel-inner> div classblock-region-column1>div classblock--tw-news-galaxy block--nir-news__widget block--nir-news__widget--5806 block--column1--nir-news__widget block--column1--nir-news__widget--5806 block--71c7f386-fb60-4275-9ed1-bfe8074378fe block--71c7f386-fb60-4275-9ed1-bfe8074378fe--5806 block block-nir-news block-nir-news__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> h2 classnir-widget--label>Press Releases/h2> div classnir-widget--content> div classnir-widget--list row row-cols-1 row-cols-md-2 row-cols-xl-3 gx-5 gy-5 pt-5 > article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted col data-titleGenenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals> div classp-4 border rounded border-dark h-100 d-flex flex-column> div classllf-col-md-12 llf-px-0 lfg-details d-flex flex-column h-100 > div classnir-widget--field data-labelTitle> div classnir-widget--field h3> a href/news-releases/news-release-details/genenta-announces-long-term-follow-observations-brain-tumor-gbm hreflangen>Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals/a> /div> /div> div classnir-widget--news--date-time font-13 data-labelDate> July 1, 2025 /div> div classpt-4 mt-auto text-end> a href/news-releases/news-release-details/genenta-announces-long-term-follow-observations-brain-tumor-gbm classbtn-galaxy-plus-light aria-labelRead more about Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals>Read Morespan aria-hiddentrue>/span>/a> /div> /div> /div>/article> article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted col data-titleGenenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies> div classp-4 border rounded border-dark h-100 d-flex flex-column> div classllf-col-md-12 llf-px-0 lfg-details d-flex flex-column h-100 > div classnir-widget--field data-labelTitle> div classnir-widget--field h3> a href/news-releases/news-release-details/genenta-and-anemocyte-announce-collaboration-manufacturing hreflangen>Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies/a> /div> /div> div classnir-widget--news--date-time font-13 data-labelDate> May 7, 2025 /div> div classpt-4 mt-auto text-end> a href/news-releases/news-release-details/genenta-and-anemocyte-announce-collaboration-manufacturing classbtn-galaxy-plus-light aria-labelRead more about Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies>Read Morespan aria-hiddentrue>/span>/a> /div> /div> /div>/article> article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted col data-titleGenenta Showcases Strategic Vision at Premier Biotech Forum in Qatar> div classp-4 border rounded border-dark h-100 d-flex flex-column> div classllf-col-md-12 llf-px-0 lfg-details d-flex flex-column h-100 > div classnir-widget--field data-labelTitle> div classnir-widget--field h3> a href/news-releases/news-release-details/genenta-showcases-strategic-vision-premier-biotech-forum-qatar hreflangen>Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar/a> /div> /div> div classnir-widget--news--date-time font-13 data-labelDate> April 15, 2025 /div> div classpt-4 mt-auto text-end> a href/news-releases/news-release-details/genenta-showcases-strategic-vision-premier-biotech-forum-qatar classbtn-galaxy-plus-light aria-labelRead more about Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar>Read Morespan aria-hiddentrue>/span>/a> /div> /div> /div>/article> /div> /div> /div> /div> /div> /div> nav aria-labelSee All News classblock--system-menu-blocklnk-news block--system-menu-blocklnk-news--5806 block--column1--system-menu-block--lnk-news block--column1--system-menu-block--lnk-news--5806 block--ed73a83f-b2cd-4e6d-9ced-aefad188512a block--ed73a83f-b2cd-4e6d-9ced-aefad188512a--5806 block block-menu navigation block-system-menublock menu--lnk-news> a href/news-events/news-releases classbtn btn-primary ndm-learn-more data-drupal-link-system-pathnode/5816>All News Releases/a> /nav> /div> /div> /div> /section> section classpy-5 home-events-section> div classcontainer llf-py-5 llf-px-lg-5 llf-px-3 radix-layouts-secondarycolumn3 panel-panel> div classpanel-panel-inner> div classblock-region-secondarycolumn3>div classblock--tw-events-galaxy block--nir-events__widget block--nir-events__widget--5806 block--secondarycolumn3--nir-events__widget block--secondarycolumn3--nir-events__widget--5806 block--0618571a-c6de-47b8-9735-5bcede5d4485 block--0618571a-c6de-47b8-9735-5bcede5d4485--5806 block block-nir-events block-nir-events__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classrow gx-5 justify-content-end> div classcol-md-4 col-lg-5 col-xl-3> h2 classnir-widget--label sticky-md-top>Events/h2> /div> div classnir-widget--content col-md-8 col-lg-7 col-xl-9> div classnir-widget--list ndm-mb-6 ndm-article-list-galaxy > article classlfg-no-content nir-widget-article>More events are coming soon./article> /div> /div> /div> /div> /div> /div> /div>div classblock--tw-events-galaxy block--nir-events__widget block--nir-events__widget--5806 block--secondarycolumn3--nir-events__widget block--secondarycolumn3--nir-events__widget--5806 block--0a378120-d627-4f61-a219-7d80c553009c block--0a378120-d627-4f61-a219-7d80c553009c--5806 block block-nir-events block-nir-events__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classrow gx-5 justify-content-end> div classnir-widget--content col-md-8 col-lg-7 col-xl-9> div classnir-widget--list ndm-mb-6 ndm-article-list-galaxy > h3 classh6 text-uppercase ndm-event-status>Past Events/h3>article classclearfix node node--nir-event--nir-widget-list node--type-nir-event node--view-mode-nir-widget-list d-flex align-items-center border-bottom py-3 mb-4 row gx-0 home-event-item data-titleBio International Convention, Boston> div classcol-12 home-event-item-details> div classd-flex justify-content-between w-100> div classflex-grow-1 pe-4> div classnir-widget--field nir-widget--event--title h5 weight-600> div classfield-nir-event-title> div classfield__item>a href/events/event-details/bio-international-convention-boston hreflangen>Bio International Convention, Boston/a>/div> /div> /div> div classnir-widget--field nir-widget--event--date font-13 mt-4> Jun 16 - June 19, 2025 /div> /div> div classd-print-none aria-hiddentrue> span classbtn-galaxy-light-arrow-right justify-content-between no-border> span>/span> /span> /div> /div> /div>/article> h3 classh6 text-uppercase ndm-event-status>Past Events/h3>article classclearfix node node--nir-event--nir-widget-list node--type-nir-event node--view-mode-nir-widget-list d-flex align-items-center border-bottom py-3 mb-4 row gx-0 home-event-item data-titleA.G.P.'s Annual Virtual Healthcare Conference> div classcol-12 home-event-item-details> div classd-flex justify-content-between w-100> div classflex-grow-1 pe-4> div classnir-widget--field nir-widget--event--title h5 weight-600> div classfield-nir-event-title> div classfield__item>a href/events/event-details/agps-annual-virtual-healthcare-conference hreflangen>A.G.P.'s Annual Virtual Healthcare Conference/a>/div> /div> /div> div classnir-widget--field nir-widget--event--date font-13 mt-4> May 22, 2025 span classlfg_time>7:00 AM EDT/span> /div> /div> div classd-print-none aria-hiddentrue> span classbtn-galaxy-light-arrow-right justify-content-between no-border> span>/span> /span> /div> /div> /div>/article> /div> /div> /div> /div> /div> /div> /div> nav aria-labelSee All Events classblock--system-menu-blocklnk-events block--system-menu-blocklnk-events--5806 block--secondarycolumn3--system-menu-block--lnk-events block--secondarycolumn3--system-menu-block--lnk-events--5806 block--0e2eba34-c620-40df-add9-f302f4742233 block--0e2eba34-c620-40df-add9-f302f4742233--5806 block block-menu navigation block-system-menublock menu--lnk-events> a href/news-events/events classbtn btn-primary ndm-learn-more data-drupal-link-system-pathnode/5821>All Events/a> /nav> /div> /div> /div> /section> section classpy-5 > div classcontainer llf-py-5 llf-px-lg-5 llf-px-3> div classrow gx-5> div classcol-md-6 mb-5 mb-md-0> div classbg-l-gray p-5 rounded h-100> div classradix-layouts-column2 panel-panel> div classpanel-panel-inner> div classblock-region-column2>div classblock--nir-assets__widget block--nir-assets__widget--5806 block--column2--nir-assets__widget block--column2--nir-assets__widget--5806 block--26490f1e-aca8-4568-a48b-8e73c04b6d29 block--26490f1e-aca8-4568-a48b-8e73c04b6d29--5806 block block-nir-assets block-nir-assets__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> h2 classnir-widget--label >Featured Reports/h2> div classnir-widget--content> div classnir-widget--list > article classlfg-no-content nir-widget-article>More information is coming soon./article> /div> /div> /div> /div> /div> /div>/div> /div> /div> /div> /div> div classcol-md-6> div classp-5 h-100 pb-0 pb-sm-5> div classradix-layouts-column3 panel-panel> div classpanel-panel-inner> div classblock-region-column3>div classblock--nir-assets__widget block--nir-assets__widget--5806 block--column3--nir-assets__widget block--column3--nir-assets__widget--5806 block--eadacda8-09cb-4e26-83e7-82d191c627ee block--eadacda8-09cb-4e26-83e7-82d191c627ee--5806 block block-nir-assets block-nir-assets__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> h2 classnir-widget--label >Financial Statements/h2> div classnir-widget--content> div classnir-widget--list > article classclearfix node node--nir-asset--nir-widget-list node--type-nir-asset node--view-mode-nir-widget-list nir-widget-article llf-border data-titleFinancial Statements as of December 31, 2023> div classllf-container-fluid-full> div classllf-row llf-no-gutters llf-flex-sm-nowrap> div classllf-col-md-12 llf-px-0 lfg-details> div classnir-widget--field nir-widget--asset--title> span classnir-widget--asset--title--title>div classfield-nir-asset-title> div classfile file--mime-application-pdf file--application-pdf field__item>a href/static-files/db77523d-9bdf-47bd-8120-02eb11e0d7df typeapplication/pdf>Financial Statements as of December 31, 2023/a>/div> /div>/span> span classnir-widget--asset--title-file-size>/span> /div> /div> /div> /div>/article> article classclearfix node node--nir-asset--nir-widget-list node--type-nir-asset node--view-mode-nir-widget-list nir-widget-article llf-border data-titleBilancio civilistico per l'esercizio chiuso al 31 dicembre 2023> div classllf-container-fluid-full> div classllf-row llf-no-gutters llf-flex-sm-nowrap> div classllf-col-md-12 llf-px-0 lfg-details> div classnir-widget--field nir-widget--asset--title> span classnir-widget--asset--title--title>div classfield-nir-asset-title> div classfile file--mime-application-pdf file--application-pdf field__item>a href/static-files/f58d43b1-a0a7-4d41-9f82-dff5595bd5c1 typeapplication/pdf>Bilancio civilistico per l'esercizio chiuso al 31 dicembre 2023/a>/div> /div>/span> span classnir-widget--asset--title-file-size>/span> /div> /div> /div> /div>/article> /div> /div> /div> /div> /div> /div> nav aria-labelSee All Test Information classblock--system-menu-blocklnk-earnings block--system-menu-blocklnk-earnings--5806 block--column3--system-menu-block--lnk-earnings block--column3--system-menu-block--lnk-earnings--5806 block--b69a9781-4aa3-4ac8-91db-5709b7a4e03d block--b69a9781-4aa3-4ac8-91db-5709b7a4e03d--5806 block block-menu navigation block-system-menublock menu--lnk-earnings> a href/financials/financial-results classbtn btn-primary ndm-learn-more data-drupal-link-system-pathnode/5871>All Financial Results/a> /nav> /div> /div> /div> /div> /div> /div> /div> /section> /div>!-- /.radix-pond --> /div>/article> /div>div idblock-client-site-websitenoticeblock classblock--website-notice-block block--website-notice-block--5806 block--content--website-notice-block block--content--website-notice-block--5806 block--0d27439e-6d28-4205-a594-eb9a9ed7cad6 block--0d27439e-6d28-4205-a594-eb9a9ed7cad6--5806 block block-nir-website-notices block-website-notice-block> /div> /div> /div> /div> /div> section classpy-5 d-print-none> div classcontainer pb-5 px-5> div classregion region-quick-links> nav aria-labelQuick Links idblock-client-site-quicklinks classblock--system-menu-blockquick-links block--system-menu-blockquick-links--5806 block--quick-links--system-menu-block--quick-links block--quick-links--system-menu-block--quick-links--5806 block--98ba32d0-bd43-4d45-a56d-99d2ea186f8a block--98ba32d0-bd43-4d45-a56d-99d2ea186f8a--5806 block block-menu navigation block-system-menublock menu--quick-links> div classrow row-cols-1 row-cols-md-2 row-cols-xl-3 gx-5 gy-5 rolelist> div classcol rolelistitem> div classpx-4 py-5 border rounded h-100 d-flex flex-column> div classh3 weight-700 text-uppercase>Events/div> div classpt-4 mt-auto text-end> a href/news-events/events classbtn-galaxy-arrow-right aria-labelLearn more about Events>Learn Morespan aria-hiddentrue>/span>/a> /div> /div> /div> div classcol rolelistitem> div classpx-4 py-5 border rounded h-100 d-flex flex-column> div classh3 weight-700 text-uppercase>News Releases/div> div classpt-4 mt-auto text-end> a href/news-events/news-releases classbtn-galaxy-arrow-right aria-labelLearn more about News Releases>Learn Morespan aria-hiddentrue>/span>/a> /div> /div> /div> div classcol rolelistitem> div classpx-4 py-5 border rounded h-100 d-flex flex-column> div classh3 weight-700 text-uppercase>Presentations/div> div classpt-4 mt-auto text-end> a href/news-events/presentations classbtn-galaxy-arrow-right aria-labelLearn more about Presentations>Learn Morespan aria-hiddentrue>/span>/a> /div> /div> /div> div classcol rolelistitem> div classpx-4 py-5 border rounded h-100 d-flex flex-column> div classh3 weight-700 text-uppercase>SEC Filings/div> div classpt-4 mt-auto text-end> a href/financials/sec-filings classbtn-galaxy-arrow-right aria-labelLearn more about SEC Filings>Learn Morespan aria-hiddentrue>/span>/a> /div> /div> /div> div classcol rolelistitem> div classpx-4 py-5 border rounded h-100 d-flex flex-column> div classh3 weight-700 text-uppercase>Stock Quote & Chart/div> div classpt-4 mt-auto text-end> a href/stock/stock-quote-chart classbtn-galaxy-arrow-right aria-labelLearn more about Stock Quote & Chart>Learn Morespan aria-hiddentrue>/span>/a> /div> /div> /div> div classcol rolelistitem> div classpx-4 py-5 border rounded h-100 d-flex flex-column> div classh3 weight-700 text-uppercase>Contact Us/div> div classpt-4 mt-auto text-end> a href/ir-resources/contact-us classbtn-galaxy-arrow-right aria-labelLearn more about Contact Us>Learn Morespan aria-hiddentrue>/span>/a> /div> /div> /div> /div> /nav> /div> /div> /section> /main>footer classbg-l-gray> div classcontainer llf-py-5 llf-px-lg-5 llf-px-4 position-relative sign-up-for-email-alerts> div classmb-3> div classrow gx-5 justify-content-between> div classcol-12> div classndm-logo-container mb-2> div classndm-logo-wrap> img src/sites/g/files/knoqqb97531/themes/site/client_site/dist/images/genenta-logo_neg-300x68.png altGenenta Science Logo> /div> /div> /div> div classcol-md-6 mb-5 mb-md-0> div classregion region-template-footer> div idblock-client-site-gbfooterinfo classblock-content--nir-global-block block-content--nir-global-block--6471 block--block-content9ad48d9e-64a6-49aa-9893-3c614da1745b block--block-content9ad48d9e-64a6-49aa-9893-3c614da1745b--5806 block--template-footer--block-content--9ad48d9e-64a6-49aa-9893-3c614da1745b block--template-footer--block-content--9ad48d9e-64a6-49aa-9893-3c614da1745b--5806 block--83dac90b-b8c7-49e9-9e82-d4ed6cfcb96d block--83dac90b-b8c7-49e9-9e82-d4ed6cfcb96d--5806 block block-block-content block-block-content9ad48d9e-64a6-49aa-9893-3c614da1745b> div classfield field--name-field-nir-global-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>div classrow>div classcol-lg-6>p>strong>ITALY/strong>br>strong>Dibit – San Raffaele Hospital/strong>br>Via Olgettina, 58br>20132 Milano/p>/div>div classcol-lg-6>p>strong>UNITED STATES/strong>br>strong>LaunchLabs – Alexandria Center/strong>br>430 East 29th Streetbr>New York NY 10016/p>/div>/div>/div> /div> /div> /div> /div> div classcol-md-6> form actionhttps://ir.genenta.com/ir-resources/email-alerts classfooter-alerts-form> div idblock-client-site-gbfooteremail classblock-content--nir-global-block block-content--nir-global-block--7996 block--block-contenta82c8a84-51cf-4824-9d32-166a2342f4f1 block--block-contenta82c8a84-51cf-4824-9d32-166a2342f4f1--5806 block--email-alerts--block-content--a82c8a84-51cf-4824-9d32-166a2342f4f1 block--email-alerts--block-content--a82c8a84-51cf-4824-9d32-166a2342f4f1--5806 block--57e78913-fd5e-42cd-849f-3759b24a0560 block--57e78913-fd5e-42cd-849f-3759b24a0560--5806 block block-block-content block-block-contenta82c8a84-51cf-4824-9d32-166a2342f4f1> div classfield field--name-field-nir-global-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>h2 classh5>Subscribe to our Email Alerts/h2>p>label classsmall mb-2 forirEmail1>Email Addressspan classreq-symbol aria-hiddentrue>*/span>span classvisually-hidden> Required/span>/label>/p>div classrow g-3>div classcol>input classform-control h-100 idirEmail1 namenir_email_alerts_signup_email placeholder typeemail>/div>div classcol-auto>button classbtn btn-primary typesubmit>Submit/button>/div>/div>/div> /div> /div> /form> /div> /div> /div> /div> div classbg-dark bg-black> div classcontainer llf-px-lg-5 llf-px-4> div classrow align-items-center gx-5 llf-justify-content-between> div classllf-col-sm-12 llf-col-lg-10> div classd-inline-block llf-py-3 copy-right> div classd-inline-block>© Genenta Science. All Rights Reserved /div> nav aria-labelFooter Policy Links idblock-client-site-footerpolicylinks classblock--system-menu-blockfooter-policy-links block--system-menu-blockfooter-policy-links--5871 block--copyright-links--system-menu-block--footer-policy-links block--copyright-links--system-menu-block--footer-policy-links--5871 block--1c1601f4-6dbe-4b7e-92f0-172f65bb013c block--1c1601f4-6dbe-4b7e-92f0-172f65bb013c--5871 block block-menu navigation block-system-menublock menu--footer-policy-links> ul classllf-m-0 llf-list-unstyled>li classllf-d-inline>span classcopyright-divider aria-hiddentrue> - /span>a hrefhttps://www.genenta.com/terms-and-conditions/ target_blank >Terms and conditions/a>/li>li classllf-d-inline>span classcopyright-divider aria-hiddentrue> - /span>a hrefhttps://www.genenta.com/privacy-policy target_blank >Privacy Policy/a>/li>li classllf-d-inline>span classcopyright-divider aria-hiddentrue> - /span>a hrefhttps://www.genenta.com/new-beta/whistleblowing/ target_new >Whistleblowing/a>/li>li classllf-d-inline>span classcopyright-divider aria-hiddentrue> - /span> P.IVA 08738490963 /li>/ul> /nav> /div> /div> div classllf-col-sm-12 llf-col-lg-2> div classregion region-social-links> nav aria-labelsocial media links classjustify-content-center justify-content-md-end navbar navbar-dark navbar-expand> ul classnavbar-nav navbar-expand> li classnav-item> a hrefhttps://www.linkedin.com/company/genenta/ aria-labelLinkedin opens in new tab titleLinkedin opens in new tab classnav-link hover-scale-1 d-block target_blank> span classfab fa-lg fa-linkedin aria-hiddentrue>/span> /a> /li> /ul> /nav> /div> /div> /div> /div> /div>/footer>!-- Video Modal -->div classndm-modal fade idvideoModal tabindex-1 roledialog aria-labelVideo Modal aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-xl> div classndm-modal-content> div classndm-modal-header> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classndm-modal-body> div classvideoWrapper>iframe titlevideo-player src>/iframe>/div> /div> /div> /div>/div>!-- Bio Modal -->div classndm-modal bios-modal fade idmodalBio tabindex-1 roledialog aria-labelledbymodalBioTitle aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lg roledocument> div classndm-modal-content border-0 p-4 idm-rounded> div classndm-modal-header> div classrow w-100 d-flex flex-row-reverse> div classcol text-end> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classcol-sm-12 col-md-6 col-lg-5 align-self-end> div classh4 mb-0 modal-bio-name text-primary idmodalBioTitle>!-- dynamic from JS -->/div> div classh5 body-font mb-0 modal-bio-title>!-- dynamic from JS -->/div> /div> div classcol-sm-12 col-md-4 col-lg-3 > div classportrait modal-bio-pic> !-- dynamic from JS --> /div> /div> /div> /div> div classndm-modal-body modal-bio-body>!-- dynamic from JS -->/div> /div> /div>/div>!-- Bio Offcanvas -->div classoffcanvas offcanvas-end bios-offcanvas tabindex-1 idbioCanvas aria-labelledbybiosOffcanvasLabel> div classoffcanvas-header flex-column-reverse> div classalign-self-start w-100> div classrow w-100> div classcol-md-3> div classportrait mt-5 offcanvas-bio-pic> !-- dynamic from JS --> /div> /div> div classcol-md-9> div classh4 offcanvas-title mt-5 offcanvas-bio-name idbiosOffcanvasLabel>!-- dynamic from JS -->/div> div class offcanvas-bio-title h6 body-font>!-- dynamic from JS -->/div> /div> /div> /div> button typebutton classbtn-close text-reset align-self-end data-bs-dismissoffcanvas aria-labelClose>/button> /div> div classoffcanvas-body> div classoffcanvas-bio-body>!-- dynamic from JS -->/div> /div>/div>!-- Search Modal -->div classndm-modal fade idsearchModal tabindex-1 aria-labelledbysearchModalLabel aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lg> div classndm-modal-content> div classndm-modal-header> div classh5 modal-title idsearchModalLabel>Search Investors/div> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classndm-modal-body> form action/search classrow g-3> div classcol-auto flex-grow-1> label forsiteSearch classvisually-hidden>Search this site/label> input typesearch classform-control idsiteSearch namequery placeholderSearch> /div> div classcol-auto> button typesubmit classbtn btn-primary mb-3>Submit/button> /div> /form> /div> /div> /div>/div> /div> script typetext/javascript>var s_CCSWebHostingAccount trcggenentascience;/script> script typeapplication/json data-drupal-selectordrupal-settings-json>{path:{baseUrl:\/,pathPrefix:,currentPath:node\/5806,currentPathIsAdmin:false,isFront:true,currentLanguage:en,themeUrl:sites\/g\/files\/knoqqb97531\/themes\/site\/client_site},pluralDelimiter:\u0003,suppressDeprecationErrors:true,ajaxPageState:{libraries:eJyVUgFuwyAM_FAV3rIXWAaslgXsynbW5vcjpFKVqZs6IYF9nA_kc6qF2MGKU5Av0pv2yE5cFJCxrl6ShUM2YZZIUHHhdHmDeFXJgxbRaDBKErYj5CI1og4wzZSLi0JG7ytWsvAMB6WhzuSDALFKmsN41RwUvfC5C3edC6q_RTcY2r9wGyGDUpLWiDtehP_UfolOWzly_leNed8_FvHH15bqpfXmYDim4_aK572XWzDhJ94Bc4ZU0Qywkrq94HUrfAzAyql3jZl2E24Ut5kAlm4l7c7-wKbHeVLM5d4HYpXFLRyyk_UuUwub0d8l-PZR,theme:client_site,theme_token:null},ajaxTrustedUrl:,nir_admin_use_chosen:false,nir_admin_use_select2:false,accessible_accordions:true,chairtextvars:{chairpersontext:Chair,chairtext:Chair},lfg_accordions:{no_functionality:1,speed:fast,show_text:Show All,hide_text:Hide All,show_all:0},lfg_chosen:{enabled:1,blank_text:Choose from list,disable_search:1,disable_search_threshold:10},membertextvars:{memberpersontext:Member},user:{uid:0,permissionsHash:02b8bbb61667a98cb3bf40a668ad4cac14b61020fb771ad7ee48e89153ba9810}}/script>script srchttps://code.jquery.com/jquery-3.7.1.min.js>/script>script src/sites/g/files/knoqqb97531/files/js/js_aUpJu6sw5gqMAs_Ntn4iZil3tPvf0MNHdgocgtIWOAY.js?scopefooter&delta1&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://cdnjs.cloudflare.com/ajax/libs/waypoints/4.0.1/jquery.waypoints.min.js>/script>script src/sites/g/files/knoqqb97531/files/js/js_o-lzQ3e_uMau7zwThYS7FEWKJhrJKIMaqWUtycA0rGU.js?scopefooter&delta3&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://cdn.jsdelivr.net/npm/@popperjs/core@2.11.6/dist/umd/popper.min.js>/script>script src/sites/g/files/knoqqb97531/files/js/js_qiNdM1zVXHkB8REZVd9dfUnMcjMW_Bxg2-P5joDV1dc.js?scopefooter&delta5&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://unpkg.com/aos@2.3.1/dist/aos.js>/script>script srchttps://unpkg.com/swiper@8/swiper-bundle.min.js>/script>script src/sites/g/files/knoqqb97531/files/js/js_zPpUEy7ZFui4wq9CQLawd09o_dssFvp5E4-OH_nlay8.js?scopefooter&delta8&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js crossoriginanonymous async integritysha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf>/script>script src/core/assets/vendor/ckeditor5/ckeditor5-dll/ckeditor5-dll.js?v44.0.0>/script>script src/profiles/nasdaqir/modules/custom/nir_ckeditor_datatables/js/build/datatables.js?v1.10.9>/script>script src/sites/g/files/knoqqb97531/files/js/js_bumalk77ZUCPHsLDE4DIQiaLZ43XNHGJRM6RLQCMq_8.js?scopefooter&delta12&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script> script typetext/javascript>piAId 1024551;piCId ;piHostname go.genenta.com;(function() { function async_load(){ var s document.createElement(script); s.type text/javascript; s.src (https: document.location.protocol ? https:// : http://) + piHostname + /pd.js; var c document.getElementsByTagName(script)0; c.parentNode.insertBefore(s, c); } if(window.attachEvent) { window.attachEvent(onload, async_load); } else { window.addEventListener(load, async_load, false); }})();/script> /body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]